Fred Poordad, MD, on Ethnic Differences in Telaprevir Treatment Effect
Feb 17, 2012 |
In this video Fred Poordad, MD, Chief of Hepatology and Liver Transplantation at the Comprehensive Transplant Center at Cedars-Sinai Medical Center evaluates the effect of race on the response to treatment and viral resistance profiles with telaprevir combination therapy.
America is making slow but steady progress against cancer, with a continuing decline in cancer deaths, according to a new report published online March 30 in the Journal of the National Cancer Institute. The report was coauthored by experts from the North American Association of Central Cancer Registries, the American Cancer Society, the U.S. Centers for Disease Control and Prevention, and the U.S. National Cancer Institute.